<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">ovarian </span>
   <span class="font23">carcinoma </span>
   <span class="font21">receptor </span>
   <span class="font18">receptors </span>
   <span class="font18">steroid </span>
   <span class="font17">index </span>
   <span class="font17">proliferation </span>
   <span class="font17">histological </span>
   <span class="font17">expression </span>
   <span class="font16">{border-style </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">frequency </span>
   <span class="font15">hormone </span>
   <span class="font15">observed </span>
   <span class="font15">AR, </span>
   <span class="font15">carcinoma. </span>
   <span class="font15">mucinous </span>
   <span class="font15">subtypes </span>
   <span class="font14">HGSC </span>
   <span class="font14">cancer </span>
   <span class="font14">endometrioid </span>
   <span class="font14">epithelial </span>
   <span class="font14">presence </span>
   <span class="font13">serous </span>
   <span class="font13">positive </span>
   <span class="font13">profile </span>
   <span class="font13">tumor </span>
   <span class="font13">ER, </span>
   <span class="font13">LGSC </span>
   <span class="font13">Nacional </span>
   <span class="font13">progesterone </span>
   <span class="font13">reduced </span>
   <span class="font12">(Fig. </span>
   <span class="font12">Endometrioid </span>
   <span class="font12">HGSC, </span>
   <span class="font12">combinations </span>
   <span class="font12">patients </span>
   <span class="font12">percentage </span>
   <span class="font12">px; </span>
   <span class="font12">{font-family </span>
   <span class="font12">Cancer </span>
   <span class="font12">CdMx, </span>
   <span class="font12">Oncology–. </span>
   <span class="font12">analysis </span>
   <span class="font12">cancer. </span>
   <span class="font12">cancer: </span>
   <span class="font12">co-expression </span>
   <span class="font12">estrogen </span>
   <span class="font12">font-size </span>
   <span class="font12">low </span>
   <span class="font12">subtype </span>
   <span class="font12">tumors </span>
   <span class="font12">ER− </span>
   <span class="font12">Mexico[], </span>
   <span class="font12">México, </span>
   <span class="font12">Ovarian </span>
   <span class="font12">cell </span>
   <span class="font12">cells </span>
   <span class="font12">compared </span>
   <span class="font12">double; </span>
   <span class="font12">endometrioid, </span>
   <span class="font12">evaluated </span>
   <span class="font12">expressed </span>
   <span class="font12">frequent </span>
   <span class="font12">higher </span>
   <span class="font12">obtained </span>
   <span class="font12">possible </span>
   <span class="font12">primary </span>
   <span class="font12">samples </span>
   <span class="font12">significant </span>
   <span class="font12">subtypes. </span>
   <span class="font12">versus </span>
   <span class="font11">(Biocare </span>
   <span class="font11">Gynecologic </span>
   <span class="font11">Mexico </span>
   <span class="font11">Table </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">breast </span>
   <span class="font11">high-grade </span>
   <span class="font11">previous </span>
   <span class="font11">role </span>
   <span class="font11">sexual </span>
   <span class="font11">significantly </span>
   <span class="font11">solid; </span>
   <span class="font11">study </span>
   <span class="font11">triple-negative </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(./j.ygyno...) </span>
   <span class="font11">Autónoma </span>
   <span class="font11">Departamento </span>
   <span class="font11">Medicina, </span>
   <span class="font11">PR− </span>
   <span class="font11">Universidad </span>
   <span class="font11">androgen </span>
   <span class="font11">association </span>
   <span class="font11">bold </span>
   <span class="font11">carcinoma; </span>
   <span class="font11">carcinomas </span>
   <span class="font11">cases </span>
   <span class="font11">clear </span>
   <span class="font11">clinical </span>
   <span class="font11">courier; </span>
   <span class="font11">displayed </span>
   <span class="font11">em; </span>
   <span class="font11">high </span>
   <span class="font11">hormones </span>
   <span class="font11">however, </span>
   <span class="font11">included </span>
   <span class="font11">n =  </span>
   <span class="font11">present </span>
   <span class="font11">presented </span>
   <span class="font11">profiles </span>
   <span class="font11">prognosis </span>
   <span class="font11">prognostic </span>
   <span class="font11">progression </span>
   <span class="font11">proportion </span>
   <span class="font11">pt;} </span>
   <span class="font11">reduction </span>
   <span class="font11">reported </span>
   <span class="font11">shows </span>
   <span class="font11">survival </span>
   <span class="font11">test </span>
   <span class="font11">tissue </span>
   <span class="font11">triple </span>
  </p>
 </body>
</html>
